AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Investigating Misconduct in Alzheimer's Research
This chapter explores the investigative efforts regarding alleged misconduct linked to Cassava Sciences and its Alzheimer's drug, Simufalam. It highlights the integrity concerns that arose from the data and the broader implications for patients in clinical trials, pointing to a significant crisis in neurodegenerative disease research.